| Literature DB >> 11278849 |
E M Kajkowski1, C F Lo, X Ning, S Walker, H J Sofia, W Wang, W Edris, P Chanda, E Wagner, S Vile, K Ryan, B McHendry-Rinde, S C Smith, A Wood, K J Rhodes, J D Kennedy, J Bard, J S Jacobsen, B A Ozenberger.
Abstract
Degeneration of neurons in Alzheimer's disease is mediated by beta-amyloid peptide by diverse mechanisms, which include a putative apoptotic component stimulated by unidentified signaling events. This report describes a novel beta-amyloid peptide-binding protein (denoted BBP) containing a G protein-coupling module. BBP is one member of a family of three proteins containing this conserved structure. The BBP subtype bound human beta-amyloid peptide in vitro with high affinity and specificity. Expression of BBP in cell culture induced caspase-dependent vulnerability to beta-amyloid peptide toxicity. Expression of a signaling-deficient dominant negative BBP mutant suppressed sensitivity of human Ntera-2 neurons to beta-amyloid peptide mediated toxicity. These findings suggest that BBP is a target of neurotoxic beta-amyloid peptide and provide new insight into the molecular pathophysiology of Alzheimer's disease.Entities:
Mesh:
Substances:
Year: 2001 PMID: 11278849 DOI: 10.1074/jbc.M011161200
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157